TGTX TG Therapeutics, Inc.
Stock · NasdaqCM · United States · Healthcare · US88322Q1085
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by TG Therapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
59.83 USD
+3.18%
52-week range
26.76 – 63.60
Dividend yield—
Market cap8.9B
NowoTrade score
60 Grade A
Price history
Daily prices in USD.
Updated 06 Nov 2026 21:25. Information, not advice.
Results
Next results
09 Nov 2026
in 2 days · 08:00 · estimate 0.26
Last results
0.05 vs 0.44 estimated
03 Aug 2026 · Miss -88.6%
Beat the estimate
3 of 12
9 missed · 0 in line
Average surprise
+36.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Nov 2026 08:00 | 0.26 | — | — | Upcoming |
| 03 Aug 2026 07:00 | 0.44 | 0.05 | -88.6% | Miss |
| 06 May 2026 07:00 | 0.28 | 0.18 | -35.1% | Miss |
| 26 Feb 2026 07:00 | 0.33 | 0.14 | -57.5% | Miss |
| 03 Nov 2025 07:00 | 0.22 | 0.16 | -26.3% | Miss |
| 04 Aug 2025 07:00 | 0.29 | 0.17 | -40.9% | Miss |
| 05 May 2025 07:00 | 0.17 | 0.03 | -82.8% | Miss |
| 03 Mar 2025 07:00 | 0.17 | 0.15 | -12.3% | Miss |
| 04 Nov 2024 07:00 | 0.03 | 0.02 | -40.9% | Miss |
| 06 Aug 2024 07:00 | -0.04 | 0.04 | +209.4% | Beat |
| 01 May 2024 07:00 | -0.04 | -0.07 | -55.6% | Miss |
| 28 Feb 2024 07:00 | -0.11 | -0.10 | +11.9% | Beat |
| 01 Nov 2023 07:00 | 0.10 | 0.73 | +660.4% | Beat |
| 01 Aug 2023 07:00 | -0.25 | -0.34 | -38.4% | Miss |
| 01 May 2023 07:00 | -0.34 | -0.28 | +18.0% | Beat |
| 28 Feb 2023 07:00 | -0.26 | -0.39 | -48.1% | Miss |
| 10 Nov 2022 07:00 | -0.38 | -0.26 | +31.0% | Beat |
| 08 Aug 2022 07:00 | -0.57 | -0.30 | +47.8% | Beat |
| 10 May 2022 16:00 | -0.63 | -0.51 | +19.0% | Beat |
| 01 Mar 2022 07:00 | -0.68 | -0.70 | -3.3% | Miss |
| 04 Nov 2021 07:00 | -0.57 | -0.65 | -13.7% | Miss |
| 02 Aug 2021 07:00 | -0.50 | -0.59 | -17.7% | Miss |
| 10 May 2021 07:00 | -0.50 | -0.69 | -38.5% | Miss |
| 01 Mar 2021 16:00 | -0.61 | -0.72 | -17.7% | Miss |
| 09 Nov 2020 16:00 | -0.44 | -0.73 | -65.2% | Miss |
| 10 Aug 2020 07:00 | -0.33 | -0.47 | -41.4% | Miss |
| 11 May 2020 16:00 | -0.37 | -0.48 | -28.0% | Miss |
| 02 Mar 2020 16:00 | -0.49 | -0.44 | +11.1% | Beat |
| 12 Nov 2019 07:00 | -0.35 | -0.69 | -94.4% | Miss |
| 09 Aug 2019 07:00 | -0.42 | -0.42 | 0.0% | In line |
| 10 May 2019 07:00 | -0.44 | -0.43 | +3.0% | Beat |
| 01 Mar 2019 16:00 | -0.42 | -0.69 | -62.4% | Miss |
| 09 Nov 2018 07:00 | -0.50 | -0.43 | +13.4% | Beat |
| 07 Aug 2018 16:00 | -0.50 | -0.59 | -18.0% | Miss |
| 08 May 2018 07:00 | -0.42 | -0.59 | -41.3% | Miss |
| 08 Mar 2018 07:00 | -0.41 | -0.46 | -12.2% | Miss |
| 08 Nov 2017 07:00 | -0.40 | -0.48 | -19.0% | Miss |
| 09 Aug 2017 07:00 | -0.38 | -0.45 | -18.4% | Miss |
| 05 May 2017 07:00 | -0.36 | -0.52 | -42.9% | Miss |
| 10 Mar 2017 07:00 | -0.35 | -0.48 | -37.9% | Miss |
| 07 Nov 2016 07:00 | -0.30 | -0.50 | -64.5% | Miss |
| 08 Aug 2016 07:00 | -0.27 | -0.33 | -20.4% | Miss |
| 10 May 2016 16:00 | -0.34 | -0.28 | +17.2% | Beat |
| 07 Mar 2016 16:00 | -0.30 | -0.37 | -24.2% | Miss |
| 09 Nov 2015 07:00 | -0.37 | -0.28 | +24.3% | Beat |
| 10 Aug 2015 07:00 | -0.33 | -0.38 | -14.0% | Miss |
| 04 May 2015 17:00 | -0.33 | -0.39 | -18.2% | Miss |
| 11 Mar 2015 17:00 | -0.25 | -0.48 | -88.2% | Miss |
| 10 Nov 2014 16:00 | -0.32 | -0.36 | -11.6% | Miss |
| 21 Jul 2014 16:00 | -0.21 | -0.36 | -67.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 616.3M | +87.3% | 447.2M | 72.6% | 2.77 | +1,746.7% | -25M |
| 2024 | 329M | +40.8% | 23.4M | 7.1% | 0.15 | +66.7% | -40.6M |
| 2023 | 233.7M | +8,290.0% | 12.7M | 5.4% | 0.09 | +106.2% | -31.4M |
| 2022 | 2.8M | — | -223.8M | -8,036.3% | -1.46 | — | -176.2M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 29 Feb 2024 | 17.85 | 18.08 | 16.89 | 17.22 | -2.33% | 6,206,300 | |
| 28 Feb 2024 | 16.18 | 18.89 | 15.90 | 17.63 | +26.74% | 16,649,200 | |
| 27 Feb 2024 | 13.82 | 14.07 | 13.35 | 13.91 | +4.12% | 6,059,000 | |
| 26 Feb 2024 | 13.50 | 13.73 | 13.00 | 13.36 | +0.30% | 4,995,200 | |
| 23 Feb 2024 | 13.36 | 13.56 | 13.19 | 13.32 | -0.89% | 2,402,900 | |
| 22 Feb 2024 | 13.13 | 13.60 | 12.90 | 13.44 | +3.23% | 3,681,300 | |
| 21 Feb 2024 | 13.01 | 13.28 | 12.84 | 13.02 | -1.59% | 3,085,200 | |
| 20 Feb 2024 | 13.75 | 13.86 | 13.17 | 13.23 | -4.34% | 3,879,100 | |
| 16 Feb 2024 | 14.21 | 14.23 | 13.81 | 13.83 | -3.96% | 2,821,600 | |
| 15 Feb 2024 | 14.35 | 14.62 | 14.11 | 14.40 | +1.48% | 2,564,000 | |
| 14 Feb 2024 | 14.25 | 14.39 | 13.90 | 14.19 | +1.87% | 2,827,200 | |
| 13 Feb 2024 | 14.48 | 14.56 | 13.80 | 13.93 | -8.23% | 4,865,300 | |
| 12 Feb 2024 | 14.91 | 15.19 | 14.68 | 15.18 | +2.99% | 3,759,200 | |
| 09 Feb 2024 | 14.83 | 15.10 | 14.60 | 14.74 | +0.68% | 3,808,800 | |
| 08 Feb 2024 | 14.32 | 14.82 | 13.96 | 14.64 | +1.88% | 3,950,400 | |
| 07 Feb 2024 | 15.35 | 15.35 | 14.36 | 14.37 | -6.38% | 3,750,400 | |
| 06 Feb 2024 | 15.25 | 15.58 | 14.92 | 15.35 | +0.26% | 3,654,000 | |
| 05 Feb 2024 | 16.48 | 16.52 | 14.64 | 15.31 | -6.99% | 6,843,200 | |
| 02 Feb 2024 | 16.50 | 16.71 | 16.25 | 16.46 | -2.49% | 2,513,700 | |
| 01 Feb 2024 | 16.39 | 17.11 | 15.98 | 16.88 | +3.94% | 3,256,900 | |
| 31 Jan 2024 | 16.10 | 17.06 | 15.83 | 16.24 | +0.43% | 5,574,100 | |
| 30 Jan 2024 | 16.18 | 16.29 | 15.90 | 16.17 | -0.49% | 2,133,500 | |
| 29 Jan 2024 | 15.83 | 16.28 | 15.61 | 16.25 | +2.85% | 3,204,300 | |
| 26 Jan 2024 | 16.03 | 16.21 | 15.79 | 15.80 | -1.13% | 5,341,400 | |
| 25 Jan 2024 | 15.69 | 16.22 | 15.66 | 15.98 | +1.98% | 2,635,700 |
Page 28 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- TG Therapeutics (TGTX) Reports Initial Phase 1 Azer Cel Data In Progressive MS (opens in a new tab) Simply Wall St. · 06 Nov 2026 01:23
- 4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates (opens in a new tab) Zacks · 04 Nov 2026 13:38
- TG Therapeutics (NASDAQ:TGTX): Affordable Growth With Strong Expansion and a Reasonable Forward Valuation (opens in a new tab) ChartMill · 04 Nov 2026 11:10
- TG Therapeutics to Host Conference Call on Third Quarter 2026 Financial Results and Business Update (opens in a new tab) 02 Nov 2026 12:30
- EBay Leads Five Stocks Near Buy Points From Resilient Sectors (opens in a new tab) Investor's Business Daily · 31 Oct 2026 12:00
- TG Therapeutics Is Up 98%, But The Story Isn't Finished (opens in a new tab) Simply Wall St. · 30 Oct 2026 18:11
- TGTX Stock Hits Fresh 52-Week High Ahead Of Earnings Amid Buyout Buzz (opens in a new tab) 30 Oct 2026 18:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 57.98 USD
- Market cap
- 8.9B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 16.7 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 13.9 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 8.3 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 8.8 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 21.75× | Fair | 31.09× |
| P/E (forward) | 22.09× | Fair | 14.98× |
| Price / book | 14.05× | Weak | 3.87× |
| Price / sales | 11.45× | Weak | 3.42× |
| EV / EBITDA | 61.76× | Weak | 13.22× |
| Free cash flow yield | 0.6% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 82.4% | Good | 59.2% |
| Operating margin | 9% | Fair | 7.8% |
| Net margin | 55.2% | Good | 3.4% |
| Return on equity | 100.3% | Good | 5.9% |
| Return on assets | 7.3% | Good | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 504.9% | Good | 10.8% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.25× | Fair | 0.46× |
| Net debt / EBITDA | 1.48× | Good | 1.48× |
| Interest cover | 4.61× | Fair | 3.26× |
| Current ratio | 4.27× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow TGTX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.